Tarsus Pharmaceuticals (TARS) Q1 2023 Earnings

23MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-0.97
-0.73
-0.48
-0.24

Details

Expected EPS
-0.94
Actual EPS
-0.88
Surprise EPS
0.06
Surprise Percent
+6.38%

Description

Tarsus Pharmaceuticals (TARS) has reported earnings of -0.88 per share for Q1 2023.

0 Comments

Share your thoughts